Selected research
Industry Research
Amides Anesthetic Industry Research Report 2026
Market perspective
The global Amides Anesthetic market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Amides Anesthetic is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Amides Anesthetic is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Amides Anesthetic is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Amides Anesthetic include Sun Pharmaceutical, Kelun, Rundu Pharma, Johnson & Johnson, Novartis, Mylan, Lifeon, Jumpcan Pharmaceutical and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Amides Anesthetic market in terms of revenue (US$ million) and, where applicable, sales volume (Kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Amides Anesthetic Market by Company
Sun Pharmaceutical
Kelun
Rundu Pharma
Johnson & Johnson
Novartis
Mylan
Lifeon
Jumpcan Pharmaceutical
Pfizer
Hengrui
B. Braun
AstraZeneca
Zoetis
Pacira
Hospira
Hikma Pharmaceuticals
Endo Pharmaceuticals
Baxter International
Amides Anesthetic Segment by Type
Short-Acting
Long-Acting
Medium-Acting
Amides Anesthetic Segment by Application
Hospital
Clinic
Amides Anesthetic Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Amides Anesthetic market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Amides Anesthetic and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Amides Anesthetic.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Amides Anesthetic manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Amides Anesthetic by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Amides Anesthetic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Short-Acting
- Long-Acting
- Medium-Acting
Applications
- Hospital
- Clinic
Companies covered
- Sun Pharmaceutical
- Kelun
- Rundu Pharma
- Johnson & Johnson
- Novartis
- Mylan
- Lifeon
- Jumpcan Pharmaceutical
- Pfizer
- Hengrui
- B. Braun
- AstraZeneca
- Zoetis
- Pacira
- Hospira
- Hikma Pharmaceuticals
- Endo Pharmaceuticals
- Baxter International
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Amides Anesthetic Market Size (2021-2032)
- 2.2.2 Global Amides Anesthetic Sales (2021-2032)
- 2.2.3 Global Amides Anesthetic Market Average Price (2021-2032)
- 2.3 Amides Anesthetic by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Short-Acting
- 2.3.3 Long-Acting
- 2.3.4 Medium-Acting
- 2.4 Amides Anesthetic by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Amides Anesthetic Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Amides Anesthetic Sales (Kg) of Manufacturers (2021-2026)
- 3.3 Global Amides Anesthetic Revenue of Manufacturers (2021-2026)
- 3.4 Global Amides Anesthetic Average Price by Manufacturers (2021-2026)
- 3.5 Global Amides Anesthetic Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Amides Anesthetic, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Amides Anesthetic, Product Type & Application
- 3.8 Global Manufacturers of Amides Anesthetic, Established Date
- 3.9 Global Amides Anesthetic Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Sun Pharmaceutical
- 4.1.1 Sun Pharmaceutical Company Information
- 4.1.2 Sun Pharmaceutical Business Overview
- 4.1.3 Sun Pharmaceutical Amides Anesthetic Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Sun Pharmaceutical Amides Anesthetic Product Portfolio
- 4.1.5 Sun Pharmaceutical Recent Developments
- 4.2 Kelun
- 4.2.1 Kelun Company Information
- 4.2.2 Kelun Business Overview
- 4.2.3 Kelun Amides Anesthetic Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Kelun Amides Anesthetic Product Portfolio
- 4.2.5 Kelun Recent Developments
- 4.3 Rundu Pharma
- 4.3.1 Rundu Pharma Company Information
- 4.3.2 Rundu Pharma Business Overview
- 4.3.3 Rundu Pharma Amides Anesthetic Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Rundu Pharma Amides Anesthetic Product Portfolio
- 4.3.5 Rundu Pharma Recent Developments
- 4.4 Johnson & Johnson
- 4.4.1 Johnson & Johnson Company Information
- 4.4.2 Johnson & Johnson Business Overview
- 4.4.3 Johnson & Johnson Amides Anesthetic Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Johnson & Johnson Amides Anesthetic Product Portfolio
- 4.4.5 Johnson & Johnson Recent Developments
- 4.5 Novartis
- 4.5.1 Novartis Company Information
- 4.5.2 Novartis Business Overview
- 4.5.3 Novartis Amides Anesthetic Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Novartis Amides Anesthetic Product Portfolio
- 4.5.5 Novartis Recent Developments
- 4.6 Mylan
- 4.6.1 Mylan Company Information
- 4.6.2 Mylan Business Overview
- 4.6.3 Mylan Amides Anesthetic Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Mylan Amides Anesthetic Product Portfolio
- 4.6.5 Mylan Recent Developments
- 4.7 Lifeon
- 4.7.1 Lifeon Company Information
- 4.7.2 Lifeon Business Overview
- 4.7.3 Lifeon Amides Anesthetic Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Lifeon Amides Anesthetic Product Portfolio
- 4.7.5 Lifeon Recent Developments
- 4.8 Jumpcan Pharmaceutical
- 4.8.1 Jumpcan Pharmaceutical Company Information
- 4.8.2 Jumpcan Pharmaceutical Business Overview
- 4.8.3 Jumpcan Pharmaceutical Amides Anesthetic Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Jumpcan Pharmaceutical Amides Anesthetic Product Portfolio
- 4.8.5 Jumpcan Pharmaceutical Recent Developments
- 4.9 Pfizer
- 4.9.1 Pfizer Company Information
- 4.9.2 Pfizer Business Overview
- 4.9.3 Pfizer Amides Anesthetic Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Pfizer Amides Anesthetic Product Portfolio
- 4.9.5 Pfizer Recent Developments
- 4.10 Hengrui
- 4.10.1 Hengrui Company Information
- 4.10.2 Hengrui Business Overview
- 4.10.3 Hengrui Amides Anesthetic Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Hengrui Amides Anesthetic Product Portfolio
- 4.10.5 Hengrui Recent Developments
- 4.11 B. Braun
- 4.11.1 B. Braun Company Information
- 4.11.2 B. Braun Business Overview
- 4.11.3 B. Braun Amides Anesthetic Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 B. Braun Amides Anesthetic Product Portfolio
- 4.11.5 B. Braun Recent Developments
- 4.12 AstraZeneca
- 4.12.1 AstraZeneca Company Information
- 4.12.2 AstraZeneca Business Overview
- 4.12.3 AstraZeneca Amides Anesthetic Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 AstraZeneca Amides Anesthetic Product Portfolio
- 4.12.5 AstraZeneca Recent Developments
- 4.13 Zoetis
- 4.13.1 Zoetis Company Information
- 4.13.2 Zoetis Business Overview
- 4.13.3 Zoetis Amides Anesthetic Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Zoetis Amides Anesthetic Product Portfolio
- 4.13.5 Zoetis Recent Developments
- 4.14 Pacira
- 4.14.1 Pacira Company Information
- 4.14.2 Pacira Business Overview
- 4.14.3 Pacira Amides Anesthetic Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Pacira Amides Anesthetic Product Portfolio
- 4.14.5 Pacira Recent Developments
- 4.15 Hospira
- 4.15.1 Hospira Company Information
- 4.15.2 Hospira Business Overview
- 4.15.3 Hospira Amides Anesthetic Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Hospira Amides Anesthetic Product Portfolio
- 4.15.5 Hospira Recent Developments
- 4.16 Hikma Pharmaceuticals
- 4.16.1 Hikma Pharmaceuticals Company Information
- 4.16.2 Hikma Pharmaceuticals Business Overview
- 4.16.3 Hikma Pharmaceuticals Amides Anesthetic Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Hikma Pharmaceuticals Amides Anesthetic Product Portfolio
- 4.16.5 Hikma Pharmaceuticals Recent Developments
- 4.17 Endo Pharmaceuticals
- 4.17.1 Endo Pharmaceuticals Company Information
- 4.17.2 Endo Pharmaceuticals Business Overview
- 4.17.3 Endo Pharmaceuticals Amides Anesthetic Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Endo Pharmaceuticals Amides Anesthetic Product Portfolio
- 4.17.5 Endo Pharmaceuticals Recent Developments
- 4.18 Baxter International
- 4.18.1 Baxter International Company Information
- 4.18.2 Baxter International Business Overview
- 4.18.3 Baxter International Amides Anesthetic Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 Baxter International Amides Anesthetic Product Portfolio
- 4.18.5 Baxter International Recent Developments
5 Global Amides Anesthetic Market Scenario by Region
- 5.1 Global Amides Anesthetic Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Amides Anesthetic Sales by Region: 2021-2032
- 5.2.1 Global Amides Anesthetic Sales by Region: 2021-2026
- 5.2.2 Global Amides Anesthetic Sales by Region: 2027-2032
- 5.3 Global Amides Anesthetic Revenue by Region: 2021-2032
- 5.3.1 Global Amides Anesthetic Revenue by Region: 2021-2026
- 5.3.2 Global Amides Anesthetic Revenue by Region: 2027-2032
- 5.4 North America Amides Anesthetic Market Facts & Figures by Country
- 5.4.1 North America Amides Anesthetic Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Amides Anesthetic Sales by Country (2021-2032)
- 5.4.3 North America Amides Anesthetic Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Amides Anesthetic Market Facts & Figures by Country
- 5.5.1 Europe Amides Anesthetic Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Amides Anesthetic Sales by Country (2021-2032)
- 5.5.3 Europe Amides Anesthetic Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Amides Anesthetic Market Facts & Figures by Country
- 5.6.1 Asia Pacific Amides Anesthetic Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Amides Anesthetic Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Amides Anesthetic Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Amides Anesthetic Market Facts & Figures by Country
- 5.7.1 South America Amides Anesthetic Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Amides Anesthetic Sales by Country (2021-2032)
- 5.7.3 South America Amides Anesthetic Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Amides Anesthetic Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Amides Anesthetic Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Amides Anesthetic Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Amides Anesthetic Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Amides Anesthetic Sales by Type (2021-2032)
- 6.1.1 Global Amides Anesthetic Sales by Type (2021-2032) & (Kg)
- 6.1.2 Global Amides Anesthetic Sales Market Share by Type (2021-2032)
- 6.2 Global Amides Anesthetic Revenue by Type (2021-2032)
- 6.2.1 Global Amides Anesthetic Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Amides Anesthetic Revenue Market Share by Type (2021-2032)
- 6.3 Global Amides Anesthetic Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Amides Anesthetic Sales by Application (2021-2032)
- 7.1.1 Global Amides Anesthetic Sales by Application (2021-2032) & (Kg)
- 7.1.2 Global Amides Anesthetic Sales Market Share by Application (2021-2032)
- 7.2 Global Amides Anesthetic Revenue by Application (2021-2032)
- 7.2.1 Global Amides Anesthetic Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Amides Anesthetic Revenue Market Share by Application (2021-2032)
- 7.3 Global Amides Anesthetic Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Amides Anesthetic Value Chain Analysis
- 8.1.1 Amides Anesthetic Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Amides Anesthetic Production Mode & Process
- 8.2 Amides Anesthetic Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Amides Anesthetic Distributors
- 8.2.3 Amides Anesthetic Customers
9 Global Amides Anesthetic Analyzing Market Dynamics
- 9.1 Amides Anesthetic Industry Trends
- 9.2 Amides Anesthetic Industry Drivers
- 9.3 Amides Anesthetic Industry Opportunities and Challenges
- 9.4 Amides Anesthetic Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst